Alx Oncology Holdings Inc
ALXO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810182
In the last 90 days, Alx Oncology Holdings Inc insiders filed 0 open-market purchases and 3 sales; 93 institutions reported holding it in 13F filings for Q2 2026, worth $217.9M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Alx Oncology Holdings Inc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +11 vs. Q1 2021
- Shares held
- 33.3M
- −198.6K (−0.6%) vs. Q1 2021
- Total value
- $1.82B
- −$646.7M (−26.2%) vs. Q1 2021
- New holders
- 22
- 38 more added
- Sold out
- 11
- 26 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALXO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 93 | $217.9M |
| Q1 2026 | 69 | $189.0M |
| Q4 2025 | 57 | $33.0M |
| Q3 2025 | 61 | $50.8M |
| Q2 2025 | 61 | $12.1M |
| Q1 2025 | 85 | $21.7M |
| Q4 2024 | 87 | $68.5M |
| Q3 2024 | 92 | $82.7M |
| Q2 2024 | 112 | $293.4M |
| Q1 2024 | 106 | $510.5M |
| Q4 2023 | 93 | $681.5M |
| Q3 2023 | 76 | $159.8M |
| Q2 2023 | 75 | $257.5M |
| Q1 2023 | 86 | $161.4M |
| Q4 2022 | 87 | $410.6M |
| Q3 2022 | 99 | $348.7M |
| Q2 2022 | 97 | $290.7M |
| Q1 2022 | 96 | $621.9M |
| Q4 2021 | 108 | $780.0M |
| Q3 2021 | 115 | $2.55B |
| Q2 2021 | 105 | $1.82B |
| Q1 2021 | 94 | $2.47B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Alx Oncology Holdings Inc; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,549,718 | $84.7M | 0.00% | +192,610+14.2% | Added |
| Wellington Management Group LLP | 2,896,890 | $158.4M | 0.03% | +235,328+8.8% | Added |
| Logos Global Management LP | 3,156,981 | $172.6M | 14.80% | 00.0% | Unchanged |
| Vivo Capital, LLC | 4,220,048 | $230.8M | 9.99% | 00.0% | Unchanged |
| venBio Partners LLC | 9,699,925 | $530.4M | 62.60% | 00.0% | Unchanged |
| Foresite Capital Management IV, LLC | 0 | $0 | 0.00% | −785,945−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −18,100−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −9,900−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −4,954−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −3,311−100.0% | Sold out |
| Cim Investment Mangement Inc | 0 | $0 | 0.00% | −3,155−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −2,960−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −1,010−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −513−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −94−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −3−100.0% | Sold out |